Trial Profile
Phase IIa study of GR-MD-02 in patients with atopic dermatitis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 18 Aug 2017
Price :
$35
*
At a glance
- Drugs Belapectin (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 18 Aug 2017 New trial record